BIO Ventures for Global Health Announces Appointment of Julie Klim as Vice President of Business Development
WASHINGTON, DC, May 24, 2006 – BIO Ventures for Global Health (BVGH) announced the appointment today of Julie Klim, previously Co-Founder and Principal at Capital Royalty L.P., as Vice President of Business Development.
“We are delighted that Julie will be driving BVGH’s business development efforts,” commented Christopher D. Earl, PhD, President and CEO of BVGH. “Her deep industry knowledge and expertise in forming biopharma partnerships will enhance BVGH’s mission of building biopharma industry commitment to global health.”
Ms. Klim has over 10 years experience in the biopharmaceutical industry. At Capital Royalty L.P., a leading private equity fund specializing in royalty based financing in the healthcare sector, Ms. Klim managed investments that capitalized royalty streams from biopharmaceutical companies and research institutions. Prior to Capital Royalty, Ms. Klim was Director, Worldwide Business Development for GlaxoSmithKline Pharmaceuticals where she negotiated numerous collaborations with life-science companies.
“I am honored to join such a dynamic organization,” stated Ms. Klim. “BVGH has already made great strides toward improving the product pipeline for neglected diseases and I look forward to working with the BVGH team and the biopharma community in continuing to advance these vital efforts.”
BVGH aims to harness the industry's discovery and development capacity to create new products that could substantially improve the lives and lifespans of people in developing countries. By evaluating market opportunities for neglected diseases and catalyzing private sector research and development, BVGH is breaking down barriers to development and actively encouraging new players to enter the global health arena. BVGH works to assemble partnerships among companies, non-profit organizations, research institutions, donors and investors to build commitment and funding around the most compelling global health projects. BVGH was spun out of the Biotechnology Industry Organization (BIO), and is supported by the Bill and Melinda Gates Foundation and the Rockefeller Foundation, as well as by leading companies in the biotech industry.
For further information visit the BVGH website at: http://www.bvgh.org.
Contact: Wendy Taylor, BVGH +1-202-962-9216 wtaylor@bvgh.org
